BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 21668963)

  • 1. Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial.
    Arnold LM; Wang F; Ahl J; Gaynor PJ; Wohlreich MM
    Arthritis Res Ther; 2011 Jun; 13(3):R86. PubMed ID: 21668963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial.
    Arnold LM; Clauw D; Wang F; Ahl J; Gaynor PJ; Wohlreich MM
    J Rheumatol; 2010 Dec; 37(12):2578-86. PubMed ID: 20843911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients.
    Murakami M; Osada K; Mizuno H; Ochiai T; Alev L; Nishioka K
    Arthritis Res Ther; 2015 Aug; 17(1):224. PubMed ID: 26296539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
    Upadhyaya HP; Arnold LM; Alaka K; Qiao M; Williams D; Mehta R
    Pediatr Rheumatol Online J; 2019 May; 17(1):27. PubMed ID: 31138224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials.
    Arnold LM; Pritchett YL; D'Souza DN; Kajdasz DK; Iyengar S; Wernicke JF
    J Womens Health (Larchmt); 2007 Oct; 16(8):1145-56. PubMed ID: 17937567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
    Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
    J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.
    Arnold LM; Zhang S; Pangallo BA
    Clin J Pain; 2012; 28(9):775-81. PubMed ID: 22971669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.
    Bennett R; Russell IJ; Choy E; Spaeth M; Mease P; Kajdasz D; Walker D; Wang F; Chappell A
    Clin Ther; 2012 Apr; 34(4):824-37. PubMed ID: 22421576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms.
    Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Marangell LB
    Curr Med Res Opin; 2011 Oct; 27(10):1849-58. PubMed ID: 21838411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial.
    Russell JI; Mease PJ; Smith TR; Kajdasz DK; Wohlreich MM; Detke MJ; Walker DJ; Chappell AS; Arnold LM
    Pain; 2008 Jun; 136(3):432-444. PubMed ID: 18395345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain.
    Konno S; Oda N; Ochiai T; Alev L
    Spine (Phila Pa 1976); 2016 Nov; 41(22):1709-1717. PubMed ID: 27831985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.
    Arnold LM; Rosen A; Pritchett YL; D'Souza DN; Goldstein DJ; Iyengar S; Wernicke JF
    Pain; 2005 Dec; 119(1-3):5-15. PubMed ID: 16298061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
    Brecht S; Courtecuisse C; Debieuvre C; Croenlein J; Desaiah D; Raskin J; Petit C; Demyttenaere K
    J Clin Psychiatry; 2007 Nov; 68(11):1707-16. PubMed ID: 18052564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study.
    Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Hann D; Marangell LB
    Curr Med Res Opin; 2011 Oct; 27(10):1859-67. PubMed ID: 21838410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of duloxetine treatment on cognition in patients with fibromyalgia.
    Mohs R; Mease P; Arnold LM; Wang F; Ahl J; Gaynor PJ; Wohlreich MM
    Psychosom Med; 2012; 74(6):628-34. PubMed ID: 22753629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial.
    Spaeth M; Bennett RM; Benson BA; Wang YG; Lai C; Choy EH
    Ann Rheum Dis; 2012 Jun; 71(6):935-42. PubMed ID: 22294641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of duloxetine in patients with fibromyalgia: tiredness subgroups.
    Bradley LA; Bennett R; Russell IJ; Wohlreich MM; Chappell AS; Wang F; D'Souza DN; Moldofsky H
    Arthritis Res Ther; 2010; 12(4):R141. PubMed ID: 20630058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: secondary analyses of four pooled randomized controlled trials of duloxetine.
    Marangell LB; Clauw DJ; Choy E; Wang F; Shoemaker S; Bradley L; Mease P; Wohlreich MM
    Pain; 2011 Jan; 152(1):31-37. PubMed ID: 20598442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of duloxetine in patients with chronic low back pain.
    Skljarevski V; Desaiah D; Liu-Seifert H; Zhang Q; Chappell AS; Detke MJ; Iyengar S; Atkinson JH; Backonja M
    Spine (Phila Pa 1976); 2010 Jun; 35(13):E578-85. PubMed ID: 20461028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.